Product
I.M. Placebo
1 clinical trial
1 indication
Indication
HealthyClinical trial
A Phase 1a, Dose-finding, Open-label Trial Followed by a Phase 1b, Double-blind, Randomised, Placebo-controlled Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of the Tuberculosis Subunit Vaccine H107e/CAF®10b in AdultsStatus: Recruiting, Estimated PCD: 2026-05-01